An Evidence-based Perspective on Warfarin and the Growing Skeleton

Overview

Journal Osteoporos Int

Specialties Endocrinology
Orthopedics

Date 2016 Apr 20

PMID 27091741

Citations 1

Authors

T Sugiyama

Y Kono

K Sekiguchi

Y T Kim

H Oda

Affiliations

Soon will be listed here.

Citing Articles

An evidence-based perspective on warfarin and the growing bone: response to Sugiyama et al.

Avila M, Pullenayegum E, Shammas A, Brandao L Osteoporos Int. 2016; 27(9):2885-2886.

PMID: 27091740 DOI: 10.1007/s00198-016-3587-6.

References

Veronese N, Bano G, Bertozzo G, Granziera S, Solmi M, Manzato E . Vitamin K antagonists' use and fracture risk: results from a systematic review and meta-analysis. J Thromb Haemost. 2015; 13(9):1665-75. DOI: 10.1111/jth.13052. View

Tufano A, Coppola A, Contaldi P, Franchini M, Di Minno G . Oral anticoagulant drugs and the risk of osteoporosis: new anticoagulants better than old?. Semin Thromb Hemost. 2015; 41(4):382-8. DOI: 10.1055/s-0034-1543999. View

Bendaly E, DiMeglio L, Fadel W, Hurwitz R . Bone density in children with single ventricle physiology. Pediatr Cardiol. 2014; 36(4):779-85. PMC: 4858165. DOI: 10.1007/s00246-014-1083-3. View

Lai H, Chien W, Chung C, Lee W, Wu T, Wang K . Atrial fibrillation, CHA2DS2-VASc score, antithrombotics and risk of non-traffic-, non-cancer-related bone fractures: A population-based cohort study. Eur J Intern Med. 2015; 26(10):798-806. DOI: 10.1016/j.ejim.2015.10.002. View

Romley J, Gong C, Jena A, Goldman D, Williams B, Peters A . Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis. BMJ. 2015; 351:h6223. PMC: 4670968. DOI: 10.1136/bmj.h6223. View

Zhao S, Lin Z, Zhu Y . Vitamin K antagonists' use and fracture risk: results from a systematic review and meta-analysis: comment. J Thromb Haemost. 2015; 14(1):219-21. DOI: 10.1111/jth.13192. View

Watzka M, Geisen C, Scheer M, Wieland R, Wiegering V, Dorner T . Bleeding and non-bleeding phenotypes in patients with GGCX gene mutations. Thromb Res. 2014; 134(4):856-65. DOI: 10.1016/j.thromres.2014.07.004. View

Avila M, Pullenayegum E, Williams S, Shammas A, Stimec J, Sochett E . Timing of low bone mineral density and predictors of bone mineral density trajectory in children on long-term warfarin: a longitudinal study. Osteoporos Int. 2015; 27(4):1547-1557. DOI: 10.1007/s00198-015-3411-8. View

Huang Z, Wan S, Lu Y, Ning L, Liu C, Fan S . Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials. Osteoporos Int. 2014; 26(3):1175-86. DOI: 10.1007/s00198-014-2989-6. View

10.

Sugiyama T, Kugimiya F, Kono S, Kim Y, Oda H . Warfarin use and fracture risk: an evidence-based mechanistic insight. Osteoporos Int. 2014; 26(3):1231-2. DOI: 10.1007/s00198-014-2912-1. View

11.

Azuma K, Shiba S, Hasegawa T, Ikeda K, Urano T, Horie-Inoue K . Osteoblast-Specific γ-Glutamyl Carboxylase-Deficient Mice Display Enhanced Bone Formation With Aberrant Mineralization. J Bone Miner Res. 2015; 30(7):1245-54. DOI: 10.1002/jbmr.2463. View

12.

Byreddy D, Bouchonville 2nd M, Lewiecki E . Drug-induced osteoporosis: from Fuller Albright to aromatase inhibitors. Climacteric. 2015; 18 Suppl 2:39-46. DOI: 10.3109/13697137.2015.1103615. View

13.

Jones A, Zacharin M, Cameron F, Simm P . Bone density assessment in a tertiary paediatric centre over 13 years: Referral patterns and limitations. J Paediatr Child Health. 2015; 51(6):608-13. DOI: 10.1111/jpc.12789. View

14.

Veronese N, Bano G, Granziera S, Solmi M, Cohen A, Correll C . Vitamin K antagonists' use and fracture risk: results from a systematic review and meta-analysis: reply. J Thromb Haemost. 2015; 14(1):221-3. DOI: 10.1111/jth.13180. View

15.

Misra D, Zhang Y, Peloquin C, Choi H, Kiel D, Neogi T . Incident long-term warfarin use and risk of osteoporotic fractures: propensity-score matched cohort of elders with new onset atrial fibrillation. Osteoporos Int. 2014; 25(6):1677-84. PMC: 4180421. DOI: 10.1007/s00198-014-2662-0. View